Development of α-synuclein immunoreactive astrocytes in the forebrain parallels stages of intraneuronal pathology in sporadic Parkinson's disease

Acta Neuropathologica

Volumn 114, Issue 3, 2007, Pages 231-241

  Braak, Heiko ^a   Sastre, Magdalena ^b   Del Tredici, Kelly ^a  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

synuclein; Astrocytes; Lewy body disease; Sporadic Parkinson's disease; Staging procedure

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN;

ADULT; AGED; AMYGDALOID NUCLEUS; ARTICLE; ASTROCYTE; AUTOPSY; BRAIN CORTEX; CELL INCLUSION; CELL LABELING; CLAUSTRUM; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; FOREBRAIN; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; LEWY BODY; MALE; NEOCORTEX; NERVE FIBER; NEURITE; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; PARKINSON DISEASE; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; SEPTUM PELLUCIDUM; THALAMUS NUCLEUS; TOPOGRAPHY;

AGED; AGED, 80 AND OVER; ALPHA-SYNUCLEIN; ASTROCYTES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INCLUSION BODIES; LEWY BODIES; MALE; MIDDLE AGED; NEURONS; PARKINSON DISEASE; PROSENCEPHALON;

EID: 34547727312     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00401-007-0244-3     Document Type: Article

References (73)

1. Arai T, Uéda K, Ikeda K, Akiyama H, Haga C, Kondo H, Kuroki N, Niizato K, Iritani S, Tsuchiya K (1999) Argyrophilic glial inclusions in the midbrain of patients with Parkinson's disease and diffuse Lewy body disease are immunopositive for NACP/alpha-synuclein. Neurosci Lett 259:83-86
2. Arima K, Uéda K, Sunohara N, Arakawa K, Hirai S, Nakamura M, Tonozuka-Uehara H, Kawai M (1998) NACP/alpha-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy. Acta Neuropathol 96:439-444
3. Borghi R, Marchese R, Negro A, Marinelli L, Forloni G, Zaccheo D, Abbruzzese G, Tabaton M (2000) Full length α-synuclein is present in cerebrospinal fluid from Parkinson's disease and normal subjects. Neurosci Lett 287:65-67
4. Braak H, Braak E (1991) Demonstration of amyloid deposits and neurofibrillary changes in whole brain sections. Brain Pathol 1:213-216
5. Braak H, Del Tredici K (2005) Preclinical and clinical stages of intracerebral inclusion body pathology in idiopathic Parkinson's disease. In: Willow JM (eds) PaPkinson's disease: progress in research. Nova Science, Hauppauge, New York, pp 1-49
6. Braak H, Del Tredici K, Rüb U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 24:197-211
7. Braak H, Ghebremedhin E, Rüb U, Bratzke H, Del Tredici K (2004) Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res 318:121-134
8. Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K (2006) Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 112:389-404
9. Braak H, Bohl JR, Müller CM, Rüb U, de Vos RAI, Del Tredici K (2006) Stanley Fahn lecture 2005: The staging procedure for the inclusion body pathology associated with sporadic Parkinson's disease reconsidered. Mov Disord 21:2042-2051
10. Canales JJ (2005) Stimulant-induced adaptations in neostriatal matrix and striosome systems: Transiting from instrumental responding to habitual behavior in drug addiction. Neurobiol Learn Mem 83:93-103
11. Clayton DF, George JM (1999) Synucleins in synaptic plasticity and neurodegenerative disorders. J Neurosci Res 58:120-129
12. Croisier E, Graeber MB (2006) Glial degeneration and reactive gliosis in alpha-synucleinopathies: The emerging concept of primary gliodegeneration. Acta Neuropathol 112:517-530
13. Del Tredici K, Braak H (2004) Idiopathic Parkinson's disease: Staging an α-synucleinopathy with a predictable pathoanatomy. In: Kahle P, Haass C (eds) Molecular mechanisms in Parkinson's disease. Landes Bioscience, Georgetown TX, pp 1-32
14. Del Tredici K, Rüb U, de Vos RAI, Bohl JRE, Braak H (2002) Where does Parkinson disease pathology begin in the brain? J Neuropathol Exp Neurol 61:413-426
15. Den Hartog Jager WA, Bethlem J (1960) The distribution of Lewy bodies in the central and autonomic nervous system in idiopathic paralysis agitans. J Neurol Neurosurg Psychiatry 23:283-290
16. Duda JE, Lee VMY, Trojanowski JQ (2000) Neuropathology of synuclein aggregates: New insights into mechanism of neurodegenerative diseases. J Neurosci Res 61:121-127
17. Duda JE, Giasson BI, Mabon ME, Lee VMY, Trojanowski JQ (2002) Novel antibodies to synuclein show abundant striatal pathology in Lewy body disease. Ann Neurol 52:205-210
18. El-Agnaf OM, Salem SA, Paleologou KE, Cooper LJ, Fullwood NJ, Gibson MJ, Curran MD, Court JA, Mann DM, Ikeda S, Cookson MR, Hardy J, Allsop D (2003) α-Synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma. FASEB J 17:1945-1947
19. El-Agnaf OM, Salem SA, Paleologou KE, Curran MD, Gibson MJ, Court JA, Schlossmacher MG, Allsop D (2005) Detection of oligomeric forms of α-synuclein protein in human plasma as a potential biomarker for Parkinson's disease. FASEB J 20:419-425
20. Folstein MF, Folstein SE, McHugh PR (1975) Mini-mental state: A practical method for grading cognitive state of patients for the clinician. J Psychiatr Res 12:189-198
21. Forno LS (1986) The Lewy body in Parkinson's disease. Adv Neurol 45:35-43
22. Forno LS (1996) Neuropathology of Parkinson's disease. J Neuropathol Exp Neurol 55:259-272
23. Gai WP, Power JH, Blumbergs PC, Blessing WW (1998) Multiple-system atrophy: A new alpha-synuclein disease? Lancet 352:547-548
24. Gai WP, Power JH, Blumbergs PC, Culvenor JG, Jensen PH (1999) Alpha-synuclein immunoisolation of glial inclusions from multiple system atrophy brain tissue reveals multiprotein components. J Neurochem 73:2093-2100
25. Gerfen CR (1984) The neostriatal mosaic: Compartmentalization of corticostriatal input and striatonigral output systems. Nature 311:461-464
26. Gerfen CR (1989) The neostriatal mosaic: Striatal patch-matrix organization is related to cortical lamination. Science 246:385-388
27. Giasson B, Jakes M, Goedert M, Duda JE, Leight S, Trojanowski JQ, Lee VM-Y (2000) A panel of epitope specific antibodies detects protein domains distributed throughout human α-synuclein in Lewy bodies of Parkinson's disease. J Neurosci Res 59:528-533
28. Gibb WRG, Scott T, Lees AJ (1991) Neuronal inclusions of Parkinson's disease. Mov Disord 6:2-11
29. Graybiel AM, Penney JB (1999) Chemical architecture of the basal ganglia. In: Björklund A, Hökfelt T (eds) Handbook of chemical neuroanatomy. The primate nervous system, Part III, vol 15. Elsevier, Amsterdam, pp 227-284
30. Hishikawa N, Hashizume Y, Yoshida M, Sobue G (2001) Widespread occurrence of argyrophilic glial inclusions in Parkinson's disease. Neuropathol Appl Neurobiol 27:362-372
31. Hishikawa N, Hashizume Y, Yoshida M, Niwa J-I, Tanaka F, Sobue G (2005)Tuft-shaped astrocytes in Lewy body disease. Acta Neuropathol 109:373-380
32. Hossain MS, Alim MA, Takeda K, Kaji H, Tomotaka S, Uéda K (2001) Limited proteolysis of NACP/alpha synuclein. J Alzheimer's Dis 3:1-8
33. Iwai A, Masliah E, Yoshimoto M, Ge N, Flanagan L, de Silva HA, Kittel A, Saitoh T (1995) The precursor protein of non-Aβ component of Alzheimer's disease amyloid is a preynaptic protein of the central nervous system. Neuron 14:467-475
34. Jakes R, Spillantini MG, Goedert M (1994) Identification of two distinct synucleins from human brain. FEBS Lett 345:27-32
35. Jensen PH, Gai WP (2001) Alpha-synuclein: Axonal transport, ligand interaction, neurodegeneration. In: Tolnay M, Probst A (eds) Neuropathology and genetics of dementia. Kluwer/Plenum, New York, pp 129-134
36. Jones EG (1984) Laminar distribution of cortical efferent cells. In: Peters A, Jones EG (eds) Cerebral cortex: Cellular components of the cerebral cortex, vol 1. Plenum, New York, London, pp 521-553
37. Klosen P, Maessen X, van den Bosch de Aguilar P (1993) PEG embedding for immunocytochemistry: Application to the analysis of immunoreactivity loss during histological processing. J Histochem Cytochem 41:455-463
38. Kramer ML, Schulz-Schaeffer WJ (2007) Presynaptic α-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies. J Neurosci 27:1405-1410
39. Kuusisto E (2004) Role of the p62 protein in the formation of neuropathological cytoplasmic inclusions. Department of Neurology Series of Reports, No. 70. University of Kuopio, Kuopio University Hospital, Kuopio
40. Kuusisto E, Parkkinen L, Alafuzoff I (2003) Morphogenesis of Lewy bodies: Dissimilar incorporation of α-synuclein, ubiquitin, and p62. J Neuropathol Exp Neurol 62:1241-1253
41. Lach B, Grimes D, Benoit B, Minkiewicz-Janda A (1992) Caudate nucleus pathology in Parkinson's disease: Ultrastructural and biochemical findings in biopsy material. Acta Neuropathol 83:352-360
42. Lavedan C (1998) The synuclein family. Genome Res 8:871-880
43. Lee HJ, Patel S, Lee SJ (2005) Intravesicular localization and exocytosis of α-synuclein and its aggregates. J Neurosci 25:6016-6024
44. Masliah E, Rockenstein E, Veinbergs I, Sagara Y, Mallory M, Hashimoto M, Mucke L (2001) β-Amyloid peptides enhance α-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease. Proc Natl Acad Sci USA 98:12245-12250
45. McNeill TH, Brown SA, Rafols JA, Shoulson I (1988) Atrophy of medium spiny striatal dendrites in advanced Parkinson's disease. Brain Res 455:148-152
46. Mori F, Tanji K, Yoshimoto M, Takahashi H, Wakabayashi K (2002) Demonstration of α-synuclein immunoreactivity in neuronal and glial cytoplasm in normal human brain tissue using proteinase K and formic acid pretreatment. Exp Neurol 176:98-104
47. Mukaetova-Ladinska EB, McKeith IG (2006) Pathophysiology of synuclein aggregation in Lewy body disease. Mech Ageing Dev 127:188-202
48. Papapetropoulos S, Basel M, Mash D (2007) Dopaminergic innervation of the human striatum in Parkinson's disease. Mov Disord 22:286-288
49. Parent A, Sato F, Wu Y, Gauthier J, Lévesque M, Parent M (2000) Organization of the basal ganglia: The importance of axonal collateralization. TINS 23(Suppl 10):S20-S27
50. Perrin RJ, Payton JE, Barnett DH, Wraight CL, Woods WS, Ye L, George JM (2003) Epitope mapping and specificity of the anti-α-synuclein monoclonal antibody Syn-1 in mouse brain and cultured cell lines. Neurosci Lett 349:133-135
51. Piao YS, Wakabayashi K, Hayashi S, Yoshimoto M, Takahashi H (2000) Aggregation of α-synuclein/NACP in the neuronal and glial cells in diffuse Lewy body disease: A survey of six patients. Clin Neuropathol 19:163-169
52. Pletnikova O, West N, Lee MK, Rudow GL, Skolasky RL, Dawson TM, Marsh L, Troncoso JC (2005) Aβ deposition is associated with enhanced cortical α-synuclein lesions in Lewy body diseases. Neurobiol Aging 26:1183-1192
53. Rüb U, Del Tredici K, Schultz C, Ghebremedhin E, de Vos RA, Jansen Steur E, Braak H (2002) Parkinson's disease: The thalamic components of the limbic loop are severely impaired by α-synuclein immunopositive inclusion body pathology. Neurobiol Aging 23:245-254
54. Sandmann-Keil D, Braak H, Okochi M, Haass C, Braak E (1999) α-Synuclein immunoreactive Lewy bodies and Lewy neurites in Parkinson's disease are detectable by an advanced silver-staining technique. Acta Neuropathol 98:461-464
55. Saper CB (1996) Role of the cerebral cortex and striatum in emotional motor response. In: Holstege G, Bandler R, Saper CB (eds) The emotional motor system. Prog Brain Res 107:537-550
56. Shoji M, Harigaya Y, Sasaki A, Uéda K, Ishiguro K, Matsubara E, Watanabe M, Ikeda M, Kanai M, Tomidokoro Y, Shizuka M, Amari M, Kosaka K, Nakazato Y, Koamoto K, Hirai S (2000) Accumulation of NACP/ alpha-synuclein in Lewy body disease and multiple system atrophy. J Neurol Neurosurg Psychiatry 68:605-608
57. Smith MA, Perry G (1994) Is a Lewy body always Lewy body? In: Korczyn A (ed) Dementia in Parkinson's disease. Monduzzi, Bologna, pp 187-193
58. Smithson KG, MacVicar BA, Hatton GI (1983) Polyethylene glycol embedding: A technique compatible with immunocytochemistry, enzyme histochemistry, histofluorescence and intracellular staining. J Neurosci Methods 7:27-41
59. Spillantini MG, Schmidt ML, Lee VM-Y, Trojanowski JQ, Jakes R, Goedert M (1997) α-Synuclein in Lewy bodies. Nature 388:839-840
60. Sung JY, Park SM, Lee CH, Um JW, Lee HJ, Kim J, Oh YJ, Lee ST, Paik SR, Chung KC (2005) Proteolytic cleavage of extracellular secreted α-synuclein via matrix metalloproteinases. J Biol Chem 280:25216-25224
61. Takeda A, Hashimoto M, Mallory M, Sundsumo M, Hansen L, Sisk A, Masliah E (1998) Abnormal distribution of the non-Aβ component of Alzheimer's disease amyloid precursor/α-synuclein in Lewy body disease as revealed by proteinase K and formic acid pretreatment. Lab Invest 78:1169-1177
62. Takeda A, Hashimoto M, Mallory M, Sundsumo M, Hansen L, Masliah E (2000) C-terminal α-synuclein immunoreactivity in structures other than Lewy bodies in neurodegenerative disorders. Acta Neuropathol 99:296-304
63. Tanji K, Imaizumi T, Yoshida H, Mori F, Yoshimoto M, Satoh K, Wakabayashi K (2001) Expression of α-synuclein in a human glioma cell line and its up-regulation by interleukin-1β. NeuroReport 12:1909-1912
64. Terada S, Ishizu H, Yokota O, Tsuchiya K, Nakashima H, Ishihara T, Fujita D, Uéda K, Ikeda K, Kuroda S (2003) Glial involvement in diffuse Lewy body disease. Acta Neuropathol 105:163-169
65. Tofaris GK, Spillantini MG (2005) Alpha-synuclein dysfunctions in Lewy body diseases. Mov Disord 20(Suppl 112):S37-S44
66. Togo T, Iseki E, Marui W, Akiyama H, Uéda K, Kosaka K (2001) Glial involvement in the degeneration process of Lewy body-bearing neurons and the degradation process of Lewy bodies in brains of dementia with Lewy bodies. J Neurol Sci 184:71-75
67. Tu PH, Galvin JE, Baba M, Giasson B, Tomita T, Leight S, Nakajo S, Iwatsubo T, Trojanowski JQ, Lee VM (1998) Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein. Ann Neurol 44:415-422
68. Uéda K, Fukushima H, Masliah E, Xia Y, Iwai A, Yoshimoto M, Otero DA, Kondo J, Ihara Y, Saitoh T (1993) Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proc Natl Acad Sci USA 90:11282-11286
69. Vertesi A, Lever JA, Molloy DW, Sanderson B, Tuttle I, Pokoradi L, Principi E (2001) Standardized mini-mental state examination. Use and interpretation. Can Fam Physician 47:2018-2023
70. Wakabayashi K, Hansen LA, Masliah E (1995) Cortical Lewy body-containing neurons are pyramidal cells. Laser confocal imaging of double-immunolabeled sections with anti-ubiquitin and SMI32. Acta Neuropathol 89:404-408
71. Wakabayashi K, Hayashi S, Yoshimoto M, Kudo H, Takahashi H (2000) NACP/ α-synuclein-positive filamentous inclusions in astrocytes and oligodendrocytes of Parkinson's disease brains. Acta Neuropathol 99:14-20
72. Wakabayashi K, Takahashi H (2005) Controversy: Is Parkinson's disease a single disease entity? Yes. Parkinsonism Rel Disord 11:S31-S37
73. Yeterian EH, Pandya DN (1994) Laminar origin of striatal and thalamic projections of the prefrontal cortex in rhesus monkeys. Exp Brain Res 99:383-398